Little Vector, Big Gene Transduction: Fragmented Genome Reassembly of Adeno-associated Virus
Year: 2010
Type: article
Abstract: Research over the past 20 years has focused on the development of adeno-associated virus (AAV) DNA delivery vectors for the treatment of several hereditary human diseases. Among viral vectors for gene therapy approaches, AAV has several advantages: (i) the majority of transgenic DNA persists as episomes rather than relying on host chromosome integration, (ii) AAV is considered nonpathogenic, and (iii) natural AAV serotypes transduce most nondividing and dividing cell types.1 Furthermore, recent advancements in the understanding of functional capsid regions, as well as random capsid sequence selection techniques, demonstrate the ability to engineer AAV vectors for enhanced transduction of specific tissues as well as an enhanced ability to evade the immune system.
Source: Molecular Therapy
DOI: 10.1038/mt.2009.280
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W1974840861
